Answers are grounded in this paper and cite their sources.
An international randomized trial in Langerhans cell histiocytosis (LCH) has been initiated by the Histiocyte Society. This report reviews the rationale, design, and progress of LCH-I, which compares etoposide (VP-16) and vinblastine in the treatment of disseminated LCH. Data on the risk of etoposide-associated (therapy-induced) malignancy, in the setting of histiocytosis, are reviewed. The available evidence leads to the recommendation that the study of etoposide in LCH should be continued.
No takes yet. Share an insight, caveat, or question.
Ladisch et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: